NT-proBNP and Cardiovascular Dysfunction in Chronic Liver Disease

Abstract

Plasma NT-proBNP levels are elevated in heart disease, especially in the presence of ascites-edema syndrome and left ventricular overload. Previous studies have reported cardiovascular dysfunction correlated with the severity of liver damage. This prospective study enrolled 65 subjects with the diagnosis of liver cirrhosis, 82 with chronic hepatitis and 65 healthy subjects in the control group. In chronic hepatitis, NT-proBNP has been shown to be an early marker of diastolic dysfunction and left ventricular remodeling, while in liver cirrhosis it also correlated with portopulmonary hypertension.